FLGT logo

Fulgent Genetics (FLGT) Revenue

Annual Revenue

$289.21 M
-$329.75 M-53.27%

December 31, 2023

Summary

Performance

1-Year Change

-53.27%

3-Year Change

-31.42%

5-Year Change

+1254.56%

15-Year Change

+1444.12%

FLGT Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.98%
FLGT annual revenue is higher than 69.98% of companies in Healthcare sector

Analysts Estimate

$282.23 M
FLGT annual revenue is currently +2.47% higher than the consensus analysts' forecast

High & Low

All-time High

$992.58 M
FLGT annual revenue is currently -70.86% below its historical high of $992.58 million

3-Year Low

$289.21 M
FLGT annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FLGT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
FLGT next annual earnings announcement is scheduled for Feb 28, 2025

OtherFLGTprofitabilitymetrics:

Annual EPS

-$5.63
FLGT annual earnings per share is -$5.63

Annual Net Income

-$167.82 M
FLGT annual net profit is -$167.82 million

Annual Operating Profit

-$75.30 M
FLGT annual operating income is -$75.30 million

Annual Gross Profit

$104.46 M
FLGT annual gross profit is $104.46 million

Quarterly Revenue

$71.74 M
+$715.00 K+1.01%

September 30, 2024

Summary

Performance

3-Month Change

+1.01%

1-Year Change

-15.28%

3-Year Change

+5.97%

5-Year Change

+5.97%

FLGT Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.5%
FLGT quarterly revenue is higher than 64.5% of companies in Healthcare sector

Analysts Estimate

$75.39 M
FLGT quarterly revenue is currently -4.84% lower than the consensus analysts' forecast

High & Low

All-time High

$359.43 M
FLGT quarterly revenue is currently -80.04% below its historical high of $359.43 million

3-Year Low

$64.48 M
FLGT quarterly revenue is currently +11.26% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FLGT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FLGT next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Quarterly Gross Profit

$26.77 M
FLGT quarterly gross profit is $26.77 million

Quarterly Operating Profit

-$17.08 M
FLGT quarterly operating income is -$17.08 million

Quarterly Net Income

-$14.65 M
FLGT quarterly net profit is -$14.65 million

Quarterly EPS

-$0.48
FLGT quarterly earnings per share is -$0.48

TTM Revenue

$277.76 M
-$12.94 M-4.45%

September 30, 2024

Summary

Performance

3-Month Change

-4.45%

1-Year Change

-3.02%

3-Year Change

-55.13%

5-Year Change

-55.13%

FLGT TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.12%
FLGT TTM revenue is higher than 65.12% of companies in Healthcare sector

Analysts Estimate

$282.65 M
FLGT TTM revenue is currently -1.73% lower than the consensus analysts' forecast

High & Low

All-time High

$1.04 B
FLGT TTM revenue is currently -73.19% below its historical high of $1.04 billion

3-Year Low

$277.76 M
FLGT TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FLGT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FLGT next earnings announcement is scheduled for Feb 28, 2025

OtherFLGTprofitabilitymetrics:

TTM Gross Profit

$100.59 M
FLGT TTM gross profit is $100.59 million

TTM Operating Profit

-$88.67 M
FLGT TTM operating income is -$88.67 million

TTM Net Income

-$164.97 M
FLGT TTM net profit is -$164.97 million

TTM EPS

-$5.52
FLGT TTM earnings per share is -$5.52

FLGT Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-53.3%-15.3%-3.0%
3 y3 years-31.4%+6.0%-55.1%
5 y5 years+1254.6%+6.0%-55.1%

FLGT Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.9%at low-77.6%+11.3%-72.0%at low
5 y5-year-70.9%+789.1%-80.0%+825.4%-73.2%+753.9%
alltimeall time-70.9%>+9999.0%-80.0%+2373.0%-73.2%+9461.5%

Fulgent Genetics Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$71.74 M(+1.0%)
$277.76 M(-4.5%)
Jun 2024
-
$71.03 M(+10.1%)
$290.70 M(+1.1%)
Mar 2024
-
$64.48 M(-8.5%)
$287.53 M(-0.6%)
Dec 2023
$289.21 M(-53.3%)
$70.50 M(-16.7%)
$289.21 M(+1.0%)
Sep 2023
-
$84.69 M(+24.8%)
$286.41 M(-6.8%)
Jun 2023
-
$67.85 M(+2.5%)
$307.38 M(-15.8%)
Mar 2023
-
$66.17 M(-2.3%)
$364.87 M(-41.1%)
Dec 2022
$618.97 M(-37.6%)
$67.70 M(-35.9%)
$618.97 M(-22.9%)
Sep 2022
-
$105.66 M(-15.7%)
$802.93 M(-13.2%)
Jun 2022
-
$125.34 M(-60.9%)
$925.15 M(-3.0%)
Mar 2022
-
$320.27 M(+27.3%)
$953.42 M(-3.9%)
Dec 2021
$992.58 M(+135.4%)
$251.67 M(+10.4%)
$992.58 M(-4.2%)
Sep 2021
-
$227.87 M(+48.3%)
$1.04 B(+13.9%)
Jun 2021
-
$153.62 M(-57.3%)
$909.74 M(+17.6%)
Mar 2021
-
$359.43 M(+21.8%)
$773.39 M(+83.4%)
Dec 2020
$421.71 M(+1196.5%)
$294.98 M(+190.0%)
$421.71 M(+212.1%)
Sep 2020
-
$101.72 M(+489.1%)
$135.12 M(+208.8%)
Jun 2020
-
$17.27 M(+122.7%)
$43.75 M(+25.3%)
Mar 2020
-
$7.75 M(-7.6%)
$34.91 M(+7.3%)
DateAnnualQuarterlyTTM
Dec 2019
$32.53 M(+52.3%)
$8.39 M(-18.9%)
$32.53 M(+9.1%)
Sep 2019
-
$10.35 M(+22.8%)
$29.81 M(+18.8%)
Jun 2019
-
$8.42 M(+56.9%)
$25.09 M(+13.7%)
Mar 2019
-
$5.37 M(-5.3%)
$22.07 M(+3.4%)
Dec 2018
$21.35 M(+14.0%)
$5.67 M(+0.9%)
$21.35 M(+7.0%)
Sep 2018
-
$5.63 M(+4.2%)
$19.96 M(+6.0%)
Jun 2018
-
$5.40 M(+16.1%)
$18.84 M(+4.2%)
Mar 2018
-
$4.65 M(+8.7%)
$18.08 M(-3.5%)
Dec 2017
$18.73 M(+2.5%)
$4.28 M(-4.9%)
$18.73 M(-7.7%)
Sep 2017
-
$4.50 M(-3.0%)
$20.30 M(-2.4%)
Jun 2017
-
$4.64 M(-12.6%)
$20.81 M(+3.3%)
Mar 2017
-
$5.31 M(-9.4%)
$20.14 M(+10.2%)
Dec 2016
$18.28 M(+90.9%)
$5.85 M(+16.8%)
$18.28 M(+19.3%)
Sep 2016
-
$5.01 M(+26.2%)
$15.32 M(+15.9%)
Jun 2016
-
$3.97 M(+15.4%)
$13.22 M(+42.9%)
Mar 2016
-
$3.44 M(+18.6%)
$9.25 M(+59.2%)
Dec 2015
$9.58 M(+649.3%)
$2.90 M(-0.1%)
$5.81 M(+99.9%)
Sep 2015
-
$2.90 M
$2.90 M
Dec 2014
$1.28 M
-
-

FAQ

  • What is Fulgent Genetics annual revenue?
  • What is the all time high annual revenue for Fulgent Genetics?
  • What is Fulgent Genetics annual revenue year-on-year change?
  • What is Fulgent Genetics quarterly revenue?
  • What is the all time high quarterly revenue for Fulgent Genetics?
  • What is Fulgent Genetics quarterly revenue year-on-year change?
  • What is Fulgent Genetics TTM revenue?
  • What is the all time high TTM revenue for Fulgent Genetics?
  • What is Fulgent Genetics TTM revenue year-on-year change?

What is Fulgent Genetics annual revenue?

The current annual revenue of FLGT is $289.21 M

What is the all time high annual revenue for Fulgent Genetics?

Fulgent Genetics all-time high annual revenue is $992.58 M

What is Fulgent Genetics annual revenue year-on-year change?

Over the past year, FLGT annual revenue has changed by -$329.75 M (-53.27%)

What is Fulgent Genetics quarterly revenue?

The current quarterly revenue of FLGT is $71.74 M

What is the all time high quarterly revenue for Fulgent Genetics?

Fulgent Genetics all-time high quarterly revenue is $359.43 M

What is Fulgent Genetics quarterly revenue year-on-year change?

Over the past year, FLGT quarterly revenue has changed by -$12.94 M (-15.28%)

What is Fulgent Genetics TTM revenue?

The current TTM revenue of FLGT is $277.76 M

What is the all time high TTM revenue for Fulgent Genetics?

Fulgent Genetics all-time high TTM revenue is $1.04 B

What is Fulgent Genetics TTM revenue year-on-year change?

Over the past year, FLGT TTM revenue has changed by -$8.65 M (-3.02%)